Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Spanish Medicines Agency Authorizes Aplidin, APLICOV-PC Trial for COVID-19

americanpharmaceuticalreviewApril 30, 2020

Tag: Spanish Medicines Agency , APLICOV-PC , COVID-19 , Aplidin , SARS-CoV-2

PharmaSources Customer Service